Correlation Between Rhythm Pharmaceuticals and Vaxcyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rhythm Pharmaceuticals and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rhythm Pharmaceuticals and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rhythm Pharmaceuticals and Vaxcyte, you can compare the effects of market volatilities on Rhythm Pharmaceuticals and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rhythm Pharmaceuticals with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rhythm Pharmaceuticals and Vaxcyte.

Diversification Opportunities for Rhythm Pharmaceuticals and Vaxcyte

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Rhythm and Vaxcyte is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Rhythm Pharmaceuticals and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Rhythm Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rhythm Pharmaceuticals are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Rhythm Pharmaceuticals i.e., Rhythm Pharmaceuticals and Vaxcyte go up and down completely randomly.

Pair Corralation between Rhythm Pharmaceuticals and Vaxcyte

Given the investment horizon of 90 days Rhythm Pharmaceuticals is expected to generate 1.23 times more return on investment than Vaxcyte. However, Rhythm Pharmaceuticals is 1.23 times more volatile than Vaxcyte. It trades about 0.11 of its potential returns per unit of risk. Vaxcyte is currently generating about 0.07 per unit of risk. If you would invest  1,760  in Rhythm Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of  4,444  from holding Rhythm Pharmaceuticals or generate 252.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Rhythm Pharmaceuticals  vs.  Vaxcyte

 Performance 
       Timeline  
Rhythm Pharmaceuticals 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Rhythm Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Rhythm Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
Vaxcyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaxcyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Rhythm Pharmaceuticals and Vaxcyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rhythm Pharmaceuticals and Vaxcyte

The main advantage of trading using opposite Rhythm Pharmaceuticals and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rhythm Pharmaceuticals position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.
The idea behind Rhythm Pharmaceuticals and Vaxcyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation